COVID-19
Artificial Intelligence (AI) Tool Predicts Oxygen Need of Hospitalized COVID-19 Patients Anywhere in the World
Researchers have used artificial intelligence (AI) to predict the oxygen needs of COVID-19 patients on a global scale.
Latest COVID-19 News
- Ultrapotent Bispecific Antibodies That Can Simultaneously Bind to Two Different Antigens Neutralize SARS-CoV-2 Variants
- Novel Ultrasound Scoring System Provides Accurate COVID-19 Diagnosis and Prognosis in Less Than 10 Minutes
- World’s First COVID-19 Drug Based on Human Immunoglobulin Developed from Plasma of Recovered Patients
- Low-Cost, Portable Ventilator Based on Intelligent 3D-Printed Origami Technology Could Improve COVID-19 Treatment
- Novel Concept of Immunologic Resilience Can Accurately Predict Which COVID-19 Patients Will Advance to Severe Disease
- Study Combining Brain MRI Findings and Latest RNA Sequencing Technology to Identify Drugs for Preventing Post-COVID Cognitive Impairment
- Point-of-Care Ultrasound Predicts Clinical Outcomes in Patients with COVID-19
- AI Tool Analyzes CT Scans to Accurately Predict Which COVID-19 Patients Will Need Ventilator to Breathe
- Biomarkers Found for COVID-19 Condition in Children May Help Predict Disease Severity and Develop MIS-C Therapies
- Widely Used Beta-Blocker Costing Only USD 2 Proves Beneficial When Administered to COVID-19 Patients
- Monoclonal Antibody Treatment Combination Reduces Hospitalization Among High-Risk COVID-19 Patients
- Unsupervised AI Predicts COVID-19 Progression and Patient Survival Directly from Chest CT Images
- Once-a-Day Oral Pill to Treat and Prevent SARS-CoV-2 Infections Begins First-in-Human Study
- Therapeutic Low-Dose Heparin Significantly Reduces Major Clotting and Death in High-Risk Hospitalized COVID-19 Patients
- Gilead’s Remdesivir Delivered Orally in Capsule Could Reduce COVID Hospitalizations
- Low-Cost, Easy-to-Use Breathing Device to Help Cope with Surge in COVID-19 Cases in Poorer Resourced Healthcare Settings
- Pfizer-BioNTech’s Comirnaty Becomes First COVID-19 Vaccine to Receive Full US FDA Approval
- Moderately Ill COVID-19 Patients Treated with Therapeutic-Dose Anticoagulation Have Better Chances of Survival
- Groundbreaking Study Uses AI-Powered Image Cell Analysis to Identify New COVID-19 Drug Available at Local Pharmacies
- Newly-Identified Antibody Proves Highly Protective at Low Doses Against Broad Range of COVID-19 Virus Variants
- Over-the-Counter Acid Suppressant Could Be Secretly Helping People Survive COVID-19
- Aspirin’s Lung-Protective Effects May Decrease Ventilation, ICU Admission and Death in COVID-19 Patients
- Convalescent Plasma Shows No Significant Benefit for COVID-19 Outpatients with Early Symptoms in Latest Study
- New Innovative Method Tests Effectiveness of COVID-19 Drugs for Treatment of SARS-CoV-2 Infection
- FDA Authorizes Third Dose of Pfizer-BioNTech and Moderna COVID-19 Vaccines for Immunocompromised Individuals
- WHO Rolls Out Unprecedented Global Trial to Study New Drugs that Could Lower Mortality in COVID-19 Patients
- Siemens AI-based COVID-19 Severity Algorithm Becomes Available to Help Clinicians Predict Progression to Severe Disease
- Identification of Promising Inhibitors Could Lead to New Antiviral Drugs to Treat COVID-19 Infections
- Highly Advanced AI Model Precisely Detects COVID-19 by Analyzing Lung Images